SAN DIEGO--(BUSINESS WIRE)--March 8, 2006--MultiCell Technologies, Inc. (OTCBB:MCET), a developer of therapeutics for the treatment of degenerative neurological diseases, metabolic and endocrinological disorders, and infectious diseases, today will host a conference call and simultaneous webcast, at 11 a.m. Eastern to discuss its recent 10-KSB filing and key strategic initiatives to develop novel stem cell technologies and next-generation, medically needed therapies for global markets.
